/ EN
2025-11-26 00:00 China Policy & Regulation Industrial Planning Translated from EN

Jiangxi Floats Mutual Ethics Review for BCI

Summary The General Office of China's Jiangxi Provincial People's Government issued Several Measures for Accelerating the Development of Brain-Computer Interface Technology and Industry in Jiangxi on November 26, 2025, document number Gan Fu Ting Fa [2025] No. 29, setting out 11 measures across four areas. It was the first provincial document to follow the seven-ministry national guidance and is the only one that sets no quantitative industry targets at all. Its eleventh measure calls for implementing BCI research ethics guidelines and establishing mutual recognition of clinical research ethics review, a first among provincial documents. Other measures deploy a provincial major science and technology programme, back Ganjiang New Area in building a rehabilitation centre and a high-quality EEG dataset, and offer early regulatory engagement plus rewards for Class II and Class III innovative device approvals.
Why it matters The only provincial BCI document with no quantitative targets, its value lies entirely in institutional plumbing. It was the first to propose mutual recognition of clinical ethics review, and six months later the provincial health commission issued implementing guidelines with hard deadlines, completing a rare mechanism-to-rulebook loop.

BCIwiki (bciwiki.com) — The General Office of China's Jiangxi Provincial People's Government (江西省人民政府办公厅) issued Several Measures for Accelerating the Development of Brain-Computer Interface Technology and Industry in Jiangxi on November 26, 2025, under document number Gan Fu Ting Fa [2025] No. 29. The text contains 11 measures grouped into four areas covering innovation, technology transfer, enterprise cultivation and industrial support.

The document sets no quantitative industry targets. Its eleventh measure calls for implementing BCI research ethics guidelines and establishing a mutual recognition mechanism for clinical research ethics review. In multicentre trials, requiring every participating hospital's ethics committee to review the same protocol independently can add many months, and the mechanism targets that bottleneck. On May 26, 2026 the provincial health commission issued implementing guidelines for BCI clinical research ethics review under document number Gan Wei Ke Jiao Fa [2026] No. 8.

Other measures deploy the provincial 2030 Pioneer Project for BCI and the 2030 Voyage Plan for brain science and brain-inspired research; support provincial key laboratories, technology innovation centres and clinical medicine research centres; back Ganjiang New Area in building a BCI rehabilitation centre, a high-quality EEG industry dataset and a future-industry pilot zone; provide early engagement, case-by-case guidance and parallel research and review for products entering the special review channel for innovative medical devices run by China's National Medical Products Administration (NMPA); and reward Class II and Class III innovative device registration certificates. Personnel in the field receive support under the province's electronic information industry talent policies.

Compiled by BCIwiki from public sources

Sources · 1
jiangxi.gov.cn 2025-11-26

General Office of the Jiangxi Provincial People's Government timeline

2026-09 Jiangxi Sets 10-Day Clock for Mutual Recognition of BCI Ethics Reviews All entries →
Read original ↗
Suggest a correction Revisions · none / EN
© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About